Medulloblastoma in two successive pregnanciesAlbiruni Ryan Abdul Razak; Qasiem Nasser; Patrick Morris; David Alcutt; Liam Grogan · 2005

Determinants of the recommended phase 2 dose of molecular targeted agentsHansen, Aaron R.; Cook, Natalie; Amir, Eitan; Siu, Lillian L.; Abdul Razak, Albiruni Ryan · Cancer · 2017

A Pulmonary Lesion Which Is More Than Meets the EyeGunaratnam, Cedric; Murphy, Desmond; Razak, Albiruni Ryan Abdul; Logan, Patrick Mark; Grogan, Liam; O???Neill, Shane · Clinical Pulmonary Medicine · 2004

Carboplatin and pemetrexed in the management of malignant pleural mesothelioma: A realistic treatment option?Li, Louise; Razak, Albiruni Ryan Abdul; Hughes, Andrew · Lung Cancer · 2009

Characterization and outcomes of patients enrolled to multiple phase I cancer trialsKuehne, Nathan; Chen, Lina; McDonald, Kate; Wang, Lisa; Spreafico, Anna; Hansen, Aaron; Razak, Albiruni Ryan Abdul; Bedard, Philippe Lucien; Siu, Lillian L.; Shepshelovich, Daniel · Cancer Chemotherapy and Pharmacology · 2019

Response to Immune Checkpoint Inhibition in Two Patients with Alveolar Soft Part SarcomaLewin, Jeremy; Davidson, Scott; Anderson, Nathaniel D; Lau, Beatrice Y.; Kelly, Jacalyn; Tabori, Uri; Salah, Samer; Butler, Marcus O; Aung, Kyaw L; Shlien, Adam; Dickson, Brendan C; Abdul Razak, Albiruni Ryan · Cancer Immunology Research · 2018

Prognostic and predictive value of CA-125 in the primary treatment of epithelial ovarian cancer: potentials and pitfallsIván Díaz-Padilla; Albiruni Ryan Abdul Razak; Lucas Minig; Marcus Q. Bernardini; Josep María del Campo · 2012

Cochrane Database of Systematic Reviews (Protocols) || Chemotherapy for malignant germ cell ovarian cancer in patients with early stage, advanced and recurrent diseaseAbdul Razak, Albiruni Ryan · 1996